155 related articles for article (PubMed ID: 29984527)
1. High-throughput Docking and Molecular Dynamics Simulations towards the Identification of Novel Peptidomimetic Inhibitors against CDC7.
Makhouri FR; Ghasemi JB
Mol Inform; 2018 Nov; 37(11):e1800022. PubMed ID: 29984527
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase.
Dick SD; Federico S; Hughes SM; Pye VE; O'Reilly N; Cherepanov P
Structure; 2020 Aug; 28(8):954-962.e4. PubMed ID: 32521228
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors.
Reichelt A; Bailis JM; Bartberger MD; Yao G; Shu H; Kaller MR; Allen JG; Weidner MF; Keegan KS; Dao JH
Eur J Med Chem; 2014 Jun; 80():364-82. PubMed ID: 24793884
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the inhibitor binding and new inhibitor design to Polo-like kinase-1 Polo-box domain using computational studies.
Abdullah M; Guruprasad L
J Biomol Struct Dyn; 2019 Aug; 37(13):3410-3421. PubMed ID: 30146942
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human CDC7 kinase in complex with its activator DBF4.
Hughes S; Elustondo F; Di Fonzo A; Leroux FG; Wong AC; Snijders AP; Matthews SJ; Cherepanov P
Nat Struct Mol Biol; 2012 Nov; 19(11):1101-7. PubMed ID: 23064647
[TBL] [Abstract][Full Text] [Related]
7. Oligomers of the Cdc7/Dbf4 protein kinase exist in the yeast cell.
Shellman YG; Schauer IE; Oshiro G; Dohrmann P; Sclafani RA
Mol Gen Genet; 1998 Sep; 259(4):429-36. PubMed ID: 9790600
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
9. In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach.
Shafique S; Bibi N; Rashid S
J Theor Biol; 2016 Jan; 388():72-84. PubMed ID: 26493360
[TBL] [Abstract][Full Text] [Related]
10. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
[TBL] [Abstract][Full Text] [Related]
11. Identification of a high affinity selective inhibitor of Polo-like kinase 1 for cancer chemotherapy by computational approach.
Kumar M; Pydi SP; Sharma S; Singh TP; Kaur P
J Mol Graph Model; 2014 Jun; 51():104-12. PubMed ID: 24879322
[TBL] [Abstract][Full Text] [Related]
12. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
Ahn M; Han YH; Park JE; Kim S; Lee WC; Lee SJ; Gunasekaran P; Cheong C; Shin SY; Kim HY; Ryu EK; Murugan RN; Kim NH; Bang JK
J Med Chem; 2015 Jan; 58(1):294-304. PubMed ID: 25347203
[TBL] [Abstract][Full Text] [Related]
13. DDK dependent regulation of TOP2A at centromeres revealed by a chemical genetics approach.
Wu KZ; Wang GN; Fitzgerald J; Quachthithu H; Rainey MD; Cattaneo A; Bachi A; Santocanale C
Nucleic Acids Res; 2016 Oct; 44(18):8786-8798. PubMed ID: 27407105
[TBL] [Abstract][Full Text] [Related]
14. Maturation-associated Dbf4 expression is essential for mouse zygotic DNA replication.
Murai S; Katagiri Y; Yamashita S
Dev Growth Differ; 2014 Dec; 56(9):625-39. PubMed ID: 25348865
[TBL] [Abstract][Full Text] [Related]
15. 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase.
Kurasawa O; Homma M; Oguro Y; Miyazaki T; Mori K; Uchiyama N; Iwai K; Ohashi A; Hara H; Yoshida S; Cho N
Bioorg Med Chem; 2017 Jul; 25(14):3658-3670. PubMed ID: 28533114
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells.
Charych DH; Coyne M; Yabannavar A; Narberes J; Chow S; Wallroth M; Shafer C; Walter AO
J Cell Biochem; 2008 Jun; 104(3):1075-86. PubMed ID: 18286467
[TBL] [Abstract][Full Text] [Related]
18. Drf1, a novel regulatory subunit for human Cdc7 kinase.
Montagnoli A; Bosotti R; Villa F; Rialland M; Brotherton D; Mercurio C; Berthelsen J; Santocanale C
EMBO J; 2002 Jun; 21(12):3171-81. PubMed ID: 12065429
[TBL] [Abstract][Full Text] [Related]
19. The role of the Saccharomyces cerevisiae Cdc7-Dbf4 complex in the replication checkpoint.
Ogi H; Wang CZ; Nakai W; Kawasaki Y; Masumoto H
Gene; 2008 May; 414(1-2):32-40. PubMed ID: 18372119
[TBL] [Abstract][Full Text] [Related]
20. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.
Gong GQ; Wang K; Dai XC; Zhou Y; Basnet R; Chen Y; Yang DH; Lee WJ; Buchanan CM; Flanagan JU; Shepherd PR; Chen Y; Wang MW
Acta Pharmacol Sin; 2018 Dec; 39(12):1902-1912. PubMed ID: 30038340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
